Bioxytran, Inc. (OTCMKTS:BIXT) Sees Large Growth in Short Interest

Bioxytran, Inc. (OTCMKTS:BIXT) saw a significant growth in short interest in June. As of June 30th, there was short interest totalling 9,100 shares, a growth of 225.0% from the June 15th total of 2,800 shares. Based on an average daily trading volume, of 210,200 shares, the short-interest ratio is currently 0.0 days.

Bioxytran Stock Performance

Shares of OTCMKTS BIXT traded down $0.01 during trading on Thursday, hitting $0.09. The company had a trading volume of 77,394 shares, compared to its average volume of 96,572. The company has a market cap of $15.06 million, a P/E ratio of -2.83 and a beta of -0.85. Bioxytran has a 52 week low of $0.07 and a 52 week high of $0.35. The business’s 50-day moving average is $0.11 and its 200 day moving average is $0.12.

About Bioxytran

Bioxytran, Inc, a clinical stage pharmaceutical company, focuses on the development, manufacture, and commercialization of therapeutic drugs to address hypoxia in humans. The company's lead drug candidate is BXT-25, an oxygen-carrying small molecule consisting of bovine hemoglobin stabilized with a co-polymer for use in the treatment of hypoxic conditions in the brain resulting from stroke, and hypoxic conditions in wounds to prevent necrosis and to promote healing.